Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.58 USD | +3.34% | -5.04% | +13.48% |
05-09 | RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk | MT |
05-08 | Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.48% | 547M | |
+4.34% | 111B | |
+11.17% | 105B | |
-12.07% | 22.34B | |
-3.99% | 21.93B | |
-6.08% | 18.59B | |
-36.52% | 18.12B | |
-10.15% | 16.96B | |
+3.14% | 13.7B | |
+36.38% | 12.45B |
- Stock Market
- Equities
- IGMS Stock
- News IGM Biosciences, Inc.
- Transcript : IGM Biosciences, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 11